This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Jiangsu Vcare Pharma Tech Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovations of Yaoxiang Yue
Introduction
Yaoxiang Yue is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. His work is characterized by a focus on innovative solutions for treating conditions associated with tropomyosin receptor kinases.
Latest Patents
Yaoxiang Yue holds a patent for a "Tropomyosin receptor kinase inhibitor, preparation method therefor and use thereof." This invention discloses a pyrazolo [1,5-a]pyrimidine derivative, which is a compound designed to prevent or treat diseases linked to tropomyosin receptor kinases, especially cancers. The patent outlines the pharmaceutical composition comprising this compound and its application in medicament preparation.
Career Highlights
Yaoxiang Yue is associated with Jiangsu Vcare Pharma Tech Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on cancer treatment and other related diseases.
Collaborations
Yaoxiang Yue collaborates with notable colleagues, including Yong Wu and Wenbin Zhou, who contribute to his research initiatives and projects.
Conclusion
Yaoxiang Yue's innovative work in the pharmaceutical industry exemplifies the importance of targeted therapies in modern medicine. His contributions, particularly in the realm of tropomyosin receptor kinase inhibitors, highlight the potential for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile